Skip to main content
. 2017 Mar 3;7:43765. doi: 10.1038/srep43765

Table 3. Enriched canonical pathways by 18/1 patterned stimulation for 2 hr and 5 hr.

Pathway # mol Z-score p Molecules
2hr
IGF-1 Signalling 7 −1.13 4.41e-3 FOS, CSNK2A2, SOCS3, SHC1, PRKAG2, STAT3, SOCS5
ERK/MAPK Signalling 8 −2.12 3.76e-2 FOS, SHC1, ITGA3, PRKAG2, DUSP4, PAK7, RPS6KA1, STAT3
Tec Kinase Signalling 7 −1.63 4.62e-2 FOS, ITGA3, GNB2, STAT2, PAK7, STAT3, ITK
Axonal Guidance Signalling 15 3.80e-2 RGS3, SLIT1, BDNF, NFATC3, C9orf3, EPHA1, WNT9A, PLCH2, LIMK1, SHC1, ITGA3, PRKAG2, GNB2, PAK7, VASP
5hr
CDK5 Signalling 20 −0.47 1.07e-2 ITGB1, PPP1R14C, RAF1, BDNF, PPP2R5D, PPP2R5B, ADCY6, MAPK12, CACNA1A, CDK5R1, ADCY9, PPP1R3D, ITGA3, PPP1R12A, MAP2K2, CAPN1, PRKAG2, MRAS, PPP2R5E, MAPK7
Death Receptor Signalling 19 2.07 9.45e-3 MAP2K4, GAS2, RELA, MAP2K7, PARP8, TNKS2, FAS, ACIN1, DAXX, TRADD, TRAF2, CASP9, CRADD, TNFSF12, BID, HTRA2, CHUK, NFKBIB, TNFRSF10A
Rac signalling 20 1.34 2.29e-2 MAP2K4, ITGB1, RELA, RPS6KB1, RAF1, MAP2K7, MAP3K11, ARPC5L, MAP3K1, PIKFYVE, PIP4K2B, WASF1, CDK5R1, PAK1, ITGA3, MAP2K2, BAIAP2, MRAS, PIP5KL1, PAK7
ERK5 signalling 13 1.73 3.76e-2 IL6ST, RPS6KB1, BAD, CREB3, CREBBP, MYC, RPS6KA6, MEF2D, NTRK1, MRAS, FOSL1, MAPK7, RPS6KA1
NGF signalling 19 1.41 4.20e.2 MAP2K4, GAS2, RELA, MAP2K7, PARP8, TNKS2, FAS, ACIN1, DAXX, TRADD, TRAF2, CASP9, CRADD, TNFSF12, BID, HTRA2, CHUK, NFKBIB, TNFRSF10A

IPA analysis was performed on up- and down-regulated transcripts (>|1.4|-fold and p < 0.05) as described in Fig. 2 and mapped to cellular and molecular signalling pathways. Z-score represents the predicted pathway activation (+) or inhibition. Significance values were calculated by a Fisher’s exact test (right-tailed) to determine the probability that a pathway was attributable to chance alone. Enriched pathways are shown, demonstrating opposing activation (18/1) and inhibition (90/5) for Nerve Growth Factor (NGF) and Rac signalling (Fig. 3) important for neurite outgrowth.